1Cancer
Research UK, University of Cambridge, Cambridge, Cambridgeshire, United
Kingdom; 2Department of Biochemistry, University of Cambridge,
Cambridge, Cambridgeshire, United Kingdom; 3School of Medicine,
University of Stanford, Palo Alto, CA, United States; 4Molecular
Biotechnology Centre, University of Turin, Turin, Piedmont, Italy
A new reporter gene for MRI is described that gives rapid, intense, and reversible T1-weighted contrast enhancement. We have achieved this through the expression of Oatp1, which is a transporter for the clinically approved contrast agent gadoxetate. R1 was enhanced by over four fold in reporter expressing tissue 5 hours post intravenous gadoxetate injection, while R1 for control tissue was not significantly different than before injection. This system therefore has the